Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 16, 2022

SELL
$119.87 - $145.67 $227,753 - $276,773
-1,900 Closed
0 $0
Q3 2021

Nov 05, 2021

SELL
$128.64 - $184.79 $334,463 - $480,454
-2,600 Reduced 57.78%
1,900 $247,000
Q2 2021

Aug 10, 2021

SELL
$160.2 - $186.42 $8,009 - $9,321
-50 Reduced 1.1%
4,500 $799,000
Q1 2021

May 03, 2021

BUY
$150.19 - $173.5 $142,680 - $164,825
950 Added 26.39%
4,550 $747,000
Q4 2020

Feb 05, 2021

BUY
$140.71 - $165.05 $28,142 - $33,010
200 Added 5.88%
3,600 $594,000
Q3 2020

Nov 06, 2020

SELL
$105.46 - $144.13 $247,830 - $338,705
-2,350 Closed
0 $0
Q2 2020

Aug 13, 2020

SELL
$95.68 - $121.88 $167,440 - $213,290
-1,750 Reduced 42.68%
2,350 $259,000
Q1 2020

May 07, 2020

SELL
$87.74 - $152.74 $109,675 - $190,925
-1,250 Reduced 23.36%
4,100 $408,000
Q4 2019

Feb 07, 2020

SELL
$117.65 - $153.73 $123,532 - $161,416
-1,050 Reduced 16.41%
5,350 $798,000
Q3 2019

Nov 08, 2019

SELL
$125.18 - $143.24 $522,626 - $598,027
-4,175 Reduced 39.48%
6,400 $820,000
Q2 2019

Aug 07, 2019

SELL
$125.55 - $144.48 $85,374 - $98,246
-680 Reduced 6.04%
10,575 $0
Q1 2019

May 07, 2019

BUY
$121.81 - $142.95 $246,056 - $288,759
2,020 Added 21.87%
11,255 $0
Q4 2018

Feb 08, 2019

SELL
$115.94 - $166.74 $539,700 - $776,174
-4,655 Reduced 33.51%
9,235 $1.14 Million
Q3 2018

Nov 14, 2018

BUY
$161.01 - $180.57 $16,101 - $18,057
100 Added 0.73%
13,890 $0
Q2 2018

Aug 06, 2018

BUY
$146.33 - $183.18 $58,532 - $73,272
400 Added 2.99%
13,790 $0
Q1 2018

May 08, 2018

BUY
$135.59 - $157.16 $199,995 - $231,811
1,475 Added 12.38%
13,390 $0
Q4 2017

Feb 05, 2018

SELL
$131.06 - $150.39 $632,364 - $725,631
-4,825 Reduced 28.82%
11,915 $0
Q3 2017

Nov 06, 2017

BUY
$142.62 - $155.6 $2.39 Million - $2.6 Million
16,740
16,740 $0

Others Institutions Holding JAZZ

About Jazz Pharmaceuticals plc


  • Ticker JAZZ
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,680,700
  • Market Cap $7.71B
  • Description
  • Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...
More about JAZZ
Track This Portfolio

Track Adell Harriman & Carpenter Inc Portfolio

Follow Adell Harriman & Carpenter Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Adell Harriman & Carpenter Inc, based on Form 13F filings with the SEC.

News

Stay updated on Adell Harriman & Carpenter Inc with notifications on news.